All Type of News
Stomatitis patients up 21.8% in 5 years
Stomatis has increased by 21.8 percent or by a yearly average of 5.1 percentage points over the past five years, according to the Health Insurance Review and Assessment Service.
Its report showed that the number of...
Chong Kun Dang names new CEOChong Kun Dang Pharmaceutical Co. announced last Friday that incumbent Vice Chairman Kim Jung-woo will lead the Seoul-based drug manufacturer based on his 40-year background in ...
|
Huons files new PE drug application for marketing approval with KFDA
Huons announced last Friday that it has filed a marketing application for its new oral premature ejaculation (PE) drug (clomipramine HCl) with the Korea Food and Drug Administration.
Jointly developed by CTC Bio, c...
Competition to be seen intensifying over OTC market
A fierce battle is foreseen in the domestic market for over-the-counter (OTC) drugs, which has so far been neglected by local drugs makers, according to Yakup Shinmoon, a local trade paper.
To soften the government...
Concerns mounting over controversial contraceptive plan
The Korea Food and Drug Administration (KFDA)’s plan to reclassify contraception pills has finally foundered after some interest groups’ vehement opposition to the changes.
Despite a series of public hearings on t...
Contraceptive flip-flop unleashes national debate
Korea's health and welfare ministry said Wednesday it will keep emergency contraceptive pills on the list of medicines that require prescriptions on worries that eased regulation could lead to the misuse of such birth...
Testing of new combination drug approved by KFDA
Ildong Pharmaceutical said Wednesday it has received approval from the Korea Food and Drug Administration to conduct clinical trials of a combination drug for the treatment of hypertension and hyperlipidemia.
The d...
Hanmi set to go global
Local pharmaceutical companies are expanding their businesses abroad to enlarge and diversify their customer base while creating opportunities to improve their products through cooperation with foreign firms, industry...
Prescription rule remains unchanged for morning-after pills
The Ministry of Health and Welfare and the Korean Food and Drug Administration (KFDA) announced Wednesday the results of their review as well as the reclassification of 504 types of medicine sold in Korea, which will ...
Government to monitor side effects of morning-after pills
The Korea Food and Administration said Wednesday that they will carefully monitor the side effects of the morning-after pills and also better educate the public on the effects and uses of birth control.
The KFDA ma...
